The state of Hawaii recently heard testimony on SB 605, "Relating to PrescriptionDrugs." This bill would require prescription drug manufacturers to notify drug plans and PBMs if a proposed increase in wholesale drug prices would result in a 16% or more price increase in a  two-year period. The Senate Health Committee deferred SB 605 to a future hearing.